Oxalic Acid

Oxalic Acid

SCHEMBL9848702

N.N.N.N.O=C(O)C(=O)O.O=C(O)C(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
LDHA P00338 2/20 0.46
LDHB P07195 1/20 0.46
FFAR3 O14843 2/20 0.40
ACHE P22303 1/20 0.40
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
KDM5B Q9UGL1 1/20 0.39
OR51E2 Q9H255 3/20 0.36
EGLN1 Q9GZT9 3/20 0.33
TSHR P16473 3/20 0.33
SRR Q9GZT4 1/20 0.33
TP53 P04637 1/20 0.33
LMNA P02545 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
EGLN3 Q9H6Z9 1/20 0.33
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL27835594 1.00
Oxalic Acid SCHEMBL376790 1.00 CA1 (0.50) CA1CA2CA9LDHALDHB
Oxalic Acid SCHEMBL28432799 1.00 CA1 (0.50) CA1CA2CA9LDHALDHB
Oxalic Acid SCHEMBL2315563 1.00 CA1 (0.50) CA1CA2CA9LDHALDHB
Oxalic Acid SCHEMBL36398 1.00
Oxalic Acid SCHEMBL8153108 1.00 CA1 (0.50) CA1CA2CA9LDHALDHB
Oxalic Acid SCHEMBL36397 1.00
Oxalic Acid SCHEMBL28871148 1.00 CA1 (0.50) CA1CA2CA9LDHALDHB
Oxalic Acid SCHEMBL340012 1.00
Oxalic Acid SCHEMBL9848703 1.00 CA1 (0.50) CA1CA2CA9LDHALDHB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024037679-A1 A METHOD FOR THE PREPARATION OF SUBMICRON AND/OR MICRON FIBERS FORMED BY A MIXTURE OF CRYSTALLINE TIO2 AND V2O5 AND THE SUBMICRON AND/ OR MICRON FIBERS PREPARED BY THIS METHOD UNIVERZITA PARDUBICE (CZ) 2024-02-22 WO claimed
CN-109205672-A A method of high purity vanadic anhydride is prepared by calcium vanadate 中国科学院过程工程研究所 2019-01-15 CN claimed
US-20250256258-A1 Method of Synthesizing an Engineered Adsorbent for Selective Extraction of Lithium CHEMETICS INC. (CA) 2025-08-14 US disclosed
CN-111480257-B Comprising oligosilylphosphines electrolyte composition of acid ester 巴斯夫欧洲公司 2025-05-02 CN disclosed
CN-118284643-A Coating composition 湛新奥地利有限公司 2024-07-02 CN disclosed
US-20240092814-A1 WATER-SOLUBLE Pd(II) COMPLEX, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF AS CATALYTIC PRECURSOR Yunnan Precious Metals Laboratory Co., Ltd (CN) 2024-03-21 US disclosed
WO-2024037679-A1 A METHOD FOR THE PREPARATION OF SUBMICRON AND/OR MICRON FIBERS FORMED BY A MIXTURE OF CRYSTALLINE TIO2 AND V2O5 AND THE SUBMICRON AND/ OR MICRON FIBERS PREPARED BY THIS METHOD UNIVERZITA PARDUBICE (CZ) 2024-02-22 WO disclosed
WO-2024037679-A1 A METHOD FOR THE PREPARATION OF SUBMICRON AND/OR MICRON FIBERS FORMED BY A MIXTURE OF CRYSTALLINE TIO2 AND V2O5 AND THE SUBMICRON AND/ OR MICRON FIBERS PREPARED BY THIS METHOD UNIVERZITA PARDUBICE (CZ) 2024-02-22 WO disclosed
WO-2023221556-A1 WATER-SOLUBLE PD(II) COMPLEX, SYNTHETIC METHOD THEREFOR, AND USE THEREOF AS CATALYTIC PRECURSOR 云南贵金属实验室有限公司 2023-11-23 WO disclosed
CN-109792084-B Silyl phosphinates as electrolyte additives 巴斯夫欧洲公司 2023-05-30 CN disclosed
CN-109716578-B Electrochemical cell comprising difunctional silyl phosphonate 巴斯夫欧洲公司 2023-05-16 CN disclosed
CN-109205672-A A method of high purity vanadic anhydride is prepared by calcium vanadate 中国科学院过程工程研究所 2019-01-15 CN disclosed
CN-104655610-B The analysis method and assay method of vanadyl oxalate oxalate ion concentration 攀钢集团研究院有限公司 2018-05-01 CN disclosed
EP-0431354-A2 X-ray intensifying screen and phosphor composition EASTMAN KODAK COMPANY (US) 1991-06-12 EP disclosed
EP-0431355-A2 X-ray intensifying screen and phosphor composition EASTMAN KODAK COMPANY (US) 1991-06-12 EP disclosed
US-4983847-A REDUCED AFTERGLOW EASTMAN KODAK COMPANY (US) 1991-01-08 US disclosed
US-4972516-A A SUPPORT WITH A FLUORESCENT LAYER WITH A PHOSPHOR FOR ABSORPTION OF X-RAYS, TITANIUM ACTIVATED HAFNIUM DIOXIDE PHOSPHOR EASTMAN KODAK COMPANY (US) 1990-11-20 US disclosed
EP-0381234-A2 X-ray intensifying screen and phosphor composition EASTMAN KODAK COMPANY (US) 1990-08-08 EP disclosed
EP-0381232-A2 X-ray intensifying screen EASTMAN KODAK COMPANY (US) 1990-08-08 EP disclosed
EP-0381233-A2 Phosphor composition and process of phosphor preparation EASTMAN KODAK COMPANY (US) 1990-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240092814-A1 WATER-SOLUBLE Pd(II) COMPLEX, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF AS CATALYTIC PRECURSOR AOC2, HAO2, PDCD1LG2 CA1 60/4885CA2 27/4885CA9 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.